Herriot Tabuteau (143 out of 426 patents)
Company Badge
USPTO Data Jan 1 1976 - Oct 27 2026
143 Patents
#87 in New York, NY
#174 in New York
#2,741 in US
#5,704 in the World
Axsome Therapeutics, Inc.
Forward Citations = 6,520
1 inventor:
New York, NY, United States of America
Axsome Therapeutics, Inc.
Calculating rank
EPO Patents = 4
Forward Citations = 6,520
Loading Chart...
Loading Chart...
1 inventor (with patents filed for the assignee):
Core Competencies:
Pharmaceutical Compositions
Meloxicam
Reboxetine
Bupropion
Narcolepsy
Migraine Treatment
Dosage Forms
Enantiomerically Enriched
Cysteine
Tolfenamic Acid
Drug Modulation
143 patents:
Company Overview
Axsome Therapeutics, Inc. is a biopharmaceutical company based in New York, specializing in the development of innovative pharmaceutical compositions for the treatment of central nervous system disorders. The company focuses on advancing therapies for conditions such as narcolepsy and migraine, utilizing core technologies that include enantiomerically enriched compounds like meloxicam, reboxetine, and bupropion. Axsome is dedicated to improving patient outcomes through its research in novel dosage forms and therapeutic approaches.
Profile summary synthesized from public USPTO records and patent filings.
IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Axsome Therapeutics, Inc.. Retrieved from https://idiyas.com/company/axsome-therapeutics
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
4 patents (EPO):
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]